U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 201657
Company: HOSPIRA
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
PARICALCITOL PARICALCITOL 0.002MG/ML (0.002MG/ML) SOLUTION;INTRAVENOUS Discontinued None No No
PARICALCITOL PARICALCITOL 0.005MG/ML (0.005MG/ML) SOLUTION;INTRAVENOUS Discontinued None No No
PARICALCITOL PARICALCITOL 0.01MG/2ML (0.005MG/ML) SOLUTION;INTRAVENOUS Discontinued None No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/21/2014 ORIG-1 Approval Type 5 - New Formulation or New Manufacturer STANDARD Label (PDF)
Letter (PDF)
Review
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201657s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/201657Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2014/201657Orig1s000TOC.html
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
12/17/2019 SUPPL-6 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201657s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2019/201657Orig1s006ltr.pdf
01/11/2017 SUPPL-4 Manufacturing (CMC)

Label is not available on this site.

05/14/2015 SUPPL-2 Manufacturing (CMC)

Label is not available on this site.

04/24/2015 SUPPL-1 Manufacturing (CMC)

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
12/17/2019 SUPPL-6 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2019/201657s006lbl.pdf
10/21/2014 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/201657s000lbl.pdf
Back to Top